Bioorganic and Medicinal Chemistry Letters p. 259 - 264 (2001)
Update date:2022-08-04
Topics:
Dorn, Conrad P.
Finke, Paul E.
Oates, Bryan
Budhu, Richard J.
Mills, Sander G.
MacCoss, Malcolm
Malkowitz, Lorraine
Springer, Martin S.
Daugherty, Bruce L.
Gould, Sandra L.
DeMartino, Julie A.
Siciliano, Salvatore J.
Carella, Anthony
Carver, Gwen
Holmes, Karen
Danzeisen, Renee
Hazuda, Daria
Kessler, Joseph
Lineberger, Janet
Miller, Michael
Schleif, William A.
Emini, Emilio A.
Screening of the Merck sample collection for compounds with CCR5 receptor binding afforded (2S)-2-(3,4-dichlorophenyl)-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-[spiro(2 ,3-dihydrobenzthiophene-3,4′-piperidin-1′-yl)]butane S-oxide (4) as a potent lead structure having an IC50 binding affinity of 35 nM. Herein, we describe the discovery of this lead structure and our initial structure-activity relationship studies directed toward the requirement for and optimization of the 1-amino fragment.
View MoreJiangsu Dacheng Pharmaceutical and Chemical Co.,Ltd
Contact:+86-0517-87036900
Address:Chuzhou Chemical park, Huai'an, Jiangsu Province
Shangyu Sanhechemicals Co.,LTD.
Contact:86-0571-56696839
Address:Num.2952,Nanhuan Road,Binjiang District,Hangzhou,China
jiangsu hualin chemical co.,ltd.
Contact:86-25-87787402
Address:jaingsu,china
Contact:0550-7041128 0550-7090578
Address:Wangdian Street,Xinjie Town
Hubei Xiangxi Chemical Industry Co.,Ltd
Contact:+86-710-3454830
Address:No.7, Daqing East Road, Xiangfan City, Hubei Province, China
Doi:10.1016/S0040-4039(97)10235-0
(1997)Doi:10.1016/0020-1693(94)04440-7
(1995)Doi:10.1021/jm00318a046
(1967)Doi:10.1016/0040-4039(94)80114-2
(1994)Doi:10.1039/C8CC05634J
(2018)Doi:10.1021/ja01272a029
(1938)